Smokeless tobacco use is linked to a significantly higher risk of peripheral artery disease, with PAD incidence comparable to cigarette smoking, highlighting the need for early screening.
Short sleep duration is linked to higher peripheral artery disease risk, highlighting sleep as a modifiable factor and the need for early PAD screening.
Peripheral artery disease (PAD) is a serious complication of diabetes that significantly increases mortality risk. Diabetic patients often experience impaired circulation, which can lead to non-healing wounds, infections, and ultimately amputations. These vascular issues also raise the likelihood of cardiovascular events such as heart attacks and strokes. Early detection and intervention are critical—screening for PAD in high-risk populations (diabetics, smokers, patients over 65) can prevent severe outcomes and reduce healthcare costs. Clinicians are encouraged to integrate PAD testing into routine care to improve patient survival and quality of life.
Rheumatoid arthritis (RA) is a chronic autoimmune disease that primarily affects the joints, causing pain, swelling, and progressive damage. Peripheral artery disease (PAD), on the other hand, is a vascular condition characterized by narrowed arteries that reduce blood flow to the limbs. Both conditions are associated with systemic inflammation and Read more…
Recent research has revealed a significant link between chronic obstructive pulmonary disease (COPD) and an increased risk of peripheral artery disease (PAD) and mortality. This study highlights the importance of early detection and proactive treatment to manage these chronic conditions effectively. Learn about the key findings and practical strategies to improve health outcomes for individuals with COPD and PAD.
Twin Cities, MN — Biomedix, a pioneer in medical technology and innovation, has announced a clinical and educational sponsorship with the Western University of Health Sciences (WesternU) College of Podiatric Medicine. Established as part of Western University of Health Sciences, the College of Podiatric Medicine is at the forefront of Read more…
Biomedix has developed a unique PADnet patient-facing video for our customers! Designed to help providers educate patients about Peripheral Artery Disease and the PADnet test, this video is ideal for healthcare practices to play in waiting rooms, show to patients prior to a PADnet test, and use in any other Read more…
Twin Cities, MN— October 5th, 2023 — Biomedix, a market-leading medical technology and innovation company, was invited to screen congressional representatives and their staff at the United States Capitol with PADnet Xpress during the PAD Caucus briefing on September 27th, 2023. PAD Caucus Co-Chairs, Congressman Donald Payne, Jr. and Congressman Read more…
Have Additional Questions About PVD And The HCC v28 Model? Fill Out The Form Below To Schedule A Consultation Notice: JavaScript is required for this content. A new version (v28) of the CMS HCC risk adjustment model was finalized earlier this year. The new v28 model includes changes in the Read more…
Cigarette smoking has long been considered to be a major risk factor for Peripheral Artery Disease (PAD). However, there is less research on whether or not the use of noncombustible tobacco is associated with an elevated risk of vascular disease. A recent study was published in the American Journal of Read more…